Participate in a Study

As Orange County’s only state and federally funded Alzheimer’s Disease Research Center, UCI MIND is at the forefront of Alzheimer’s disease research. We have a variety of research participation opportunities for older adults with and without memory concerns. Click the tabs below to learn about our current research studies and clinical trials or contact our research team:

Phone: 949.824.0008
Email:  research@mind.uci.edu

SEEKING OLDER ADULTS FOR AN EXERCISE STUDY (EXERT)

Lead researcher: Steven Tam, MD

Location: UCI Campus (UCI MIND Gottschalk Medical Plaza, ICTS in Hewitt Hall, Newport Diagnostic Center, Newport Mesa YMCA, Huntington Beach Family YMCA)

Purpose: To evaluate whether 18 months of moderate to high intensity exercise will improve cognition in older adults with Mild Cognitive Impairment (MCI).

Eligibility: Adult participants ages 65 to 89 years old who have been diagnosed with MCI

Time commitment: You will be asked to complete a total of 7 clinic visits over the course of the study and participate in a structured exercise program 4 days a week for 18 months. The total time commitment is 20 months.

Anticipated benefits: You will receive an 18 month membership to the YMCA. Participating in the exercise program may or may not improve your condition. The information collected from this study may increase knowledge regarding the treatment of Alzheimer’s disease and help people in the future.

Compensation: You are eligible to receive the following compensation in cash during the course of this study:

  • $100 for each completed MRI scan; there are 2 MRI scans ($200 max).
  • $75 for each completed lumbar puncture (optional) ($150 max).
  • $75 for completing the baseline clinical visit, $50 for completing the month 12 clinical visit and $25 for completing the month 18 clinical visit ($150 max)
  • Total compensation for this study is a maximum of $500 in cash
  • Participants will not be reimbursed for travel-related expenses

Contact name: Ivy Nguyen
Phone: 949.824.0008
Emailresearch@mind.uci.edu

ARE YOU OR IS SOMEONE YOU KNOW EXPERIENCING MEMORY LOSS?

Researchers at UCI and UCLA are conducting a new study to test whether high doses of nicotinamide (a component of vitamin B3) can halt or reverse neurofibrillary tangles in Alzheimer’s disease.

Lead researcher: Joshua Grill, PhD and Steven Tam, MD

Study Title: A Phase 2, Proof-of-Concept, Double-Blind-Randomized, Placebo-Controlled Adaptive Design Trial of Nicotinamide in MCI due to AD and Mild AD Dementia

Purpose of Study: To evaluate whether nicotinamide, also known as vitamin B3 or niacinamide, can reduce phosphorylation or “over-processing” of tau (the protein that accumulates in neurofibrillary tangles) in people with Mild Cognitive Impairment or mild Alzheimer’s disease (AD) dementia.

Eligibility: Men and women, aged 50 years and above and diagnosed with Mild Cognitive Impairment or mild dementia due to Alzheimer’s disease.

Location: UCI Campus (1100 Gottschalk Medical Plaza, Irvine; ICTS at Hewitt Hall, Irvine and Newport Diagnostic Center, Newport Beach); UCLA (Center for Neurotherapeutics UCLA Medical Center 300 Medical Plaza, Westwood Blvd Los Angeles)

Time Commitment: Screening Phase (may be up to 6o days) and Treatment Phase (4 visits over a 12 month period)

Anticipated Benefits: You may or may not benefit from participating in this study. The information collected from this study may increase knowledge regarding the treatment of Alzheimer’s disease and help people in the future.

Compensation: Participants are eligible to receive the following compensation in cash during the course of this study:

  • Visit 1 completion: $50
  • Visit 2 completion: $50
  • Visit 3 completion: $50
  • Visit 4 completion: $100

The grand total compensation for this study is a maximum of $250 in cash

Reimbursement: Participants will not be reimbursed for travel-related expenses.

Contact name, UCI Department, Phone Number and Email:

Ivy Nguyen

Clinical Trials Research Inquiry Coordinator

Institute for Memory Impairments and Neurological Disorders (UCI MIND)

Alzheimer’s Disease Research Center (ADRC)

1100 Gottschalk Medical Plaza

Irvine, CA 92697-4285

(949) 824-0008

research@mind.uci.edu

 

UCI IRB Approved: 05-25-2018 | MOD# 24074 | HS# 2016-3246

SEEKING OLDER ADULTS FOR A NEW MEMORY STUDY AT UC IRVINE

Lead researcher: S. Ahmad Sajjadi, MD, PhD, MRCP

Study Title: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of MTAU9937A in Patients with Prodromal to Mild Alzheimer’s Disease

Purpose of Study: To compare the safety and effectiveness of an investigational drug called MTAU9937A versus placebo in people with Mild Cognitive Impairment (MCI) or mild Alzheimer’s disease (AD).

Eligibility: Male and female participants ages 50-80 years old, who have been diagnosed with early Alzheimer’s Disease (mild cognitive impairment or mild AD), with evidence of amyloid pathology on a brain scan. All study subjects must have an informant/care partner who can attend required study visits and can provide accurate information about the subject’s cognitive and functional abilities.

Location: UCI Campus (UCI MIND Gottschalk Medical Plaza, ICTS in Hewitt Hall, Neuro Imaging Center), Newport Diagnostic Center

Time commitment: Screening Phase (up to 8 weeks). If you are eligible for the treatment phase (which includes a double blind treatment phase and an open label phase), you will receive placebo or MTAU9937 and have approximately 45 visits over the course of up to 169 weeks.

Anticipated benefits: You may or may not receive any benefit from being in this study. If you are in the group that receives the study drug, MTAU9937, and it proves to treat your condition better than placebo, you may benefit from participating in the study, but this cannot be guaranteed. The information collected from this study may increase knowledge regarding the treatment of Alzheimer’s disease and help people in the future.

Compensation: Participants are eligible to receive the following compensation in cash during the course of this study:

Double Blind Treatment phase of this study:

  • $50 for each completed MRI scan; there are 4 MRI scans ($200 max).
  • $100 for each completed PET scan; there are up to 4 PET scans ($400 max).
  • $100 for each completed lumbar puncture; there are 3 optional lumbar punctures ($400 max).
  • $25 for each clinic visit; there are approximately 21 clinic visits ($525 max).

Open Label Extension phase of this study:

  • $50 for each completed MRI scan; there are 2 MRI scans ($100 max).
  • $100 for each completed PET scan; there is 1 PET scan ($100 max).
  • $100 for each completed lumbar puncture; there is 1 optional lumbar puncture ($100 max).
  • $25 for each clinic visit; there are approximately 24 clinic visits ($600 max).

If you decide to withdraw from the study or are withdrawn by the research team, you will receive compensation for the visits and/or procedures that you have completed.

Reimbursement: You will not be reimbursed for any out of pocket expenses, such as parking or transportation fees.

Contact name, Department, Phone Number and Email:

Ivy Nguyen

Clinical Trials Research Inquiry Coordinator

Institute for Memory Impairments and Neurological Disorders (UCI MIND)

Alzheimer’s Disease Research Center (ADRC)

1100 Gottschalk Medical Plaza

Irvine, CA 92697-4285

(949) 824-0008

research@mind.uci.edu

 

UCI IRB Approved: 06-15-2018 | MOD# 24125 | HS# 2018-4292

LONGITUDINAL STUDY

The Longitudinal Study follows people with and without memory problems annually until the end of life.  Through their lifetime commitment to research, our volunteers help us increase knowledge about memory and aging.  For example, they help us understand:

  • Differences between people who develop cognitive problems leading to Alzheimer’s disease and those who do not
  • The role of lifestyle strategies, like regular exercise, in reducing risk for Alzheimer’s disease
  • Changes in biomarkers that foreshadow Alzheimer’s disease and could lead to earlier diagnosis and treatment
What’s involved?

Expert clinicians conduct a comprehensive annual evaluation that includes:

  • Physical and neurological exams
  • Paper and pencil tests to assess memory and other cognitive abilities
  • Interview with a study partner
  • Blood draw and skin biopsy
  • Lumbar puncture
  • Genetic testing

Feedback is provided in a family conference and/or a report, as most appropriate. Upon death, with the family’s permission, we perform a brain autopsy and provide final confirmation of the diagnosis.

Am I eligible to participate?

Our investigators seek participants who meet the following criteria:

  • Age 60 or older
  • Are aging normally, without any cognitive difficulties, or have Mild Cognitive Impairment (MCI), early Alzheimer’s disease, or another dementia
  • Have a close family member or friend who can answer questions about the participant’s daily living skills
  • Are willing to participate in various research studies on brain aging that involve skin biopsy, neuroimaging and lumbar puncture
  • Are willing to donate the brain upon death (may be waived for religious or cultural reasons)

To determine eligibility, one of our research coordinators will interview you by phone and may ask you to complete some paperwork and/or come into the clinic for an in-person screening.

Is there any cost?

There is no charge to participate in any of our research studies.

What are the benefits of participating in research?

As one of our longitudinal study participants, you will benefit from:

  • Free comprehensive annual evaluations from experts, who will provide feedback and recommendations to your primary care physician, should you want them
  • Early detection of cognitive changes in healthy older adults that could respond to treatment or may signal the development of Alzheimer’s disease or another disorder
  • Annual monitoring of cognition, behavior, and daily functioning in participants with Alzheimer’s disease or another disorder to aid the family in management and planning
  • Access to treatments in development before they are widely available
  • The gratification of helping advance knowledge of brain aging aging and neurodegenerative disease
How do I join?

If you are interested in joining the Longitudinal Study or would like more information, contact 949.824.0008 or research@mind.uci.edu.

RESEARCH OPPORTUNITIES FOR ADULTS WITH DOWN SYNDROME

Brain Aging and Dementia in Down Syndrome Study

Researchers at the University of California, Irvine, under the direction of Dr. Ira T. Lott, are recruiting adults (age 18 and over, both female and male) with Down syndrome for the study, titled “Brain Aging and Dementia in Down Syndrome.” This study is funded by the National Institute on Aging. People with Down syndrome comprise a special populations of individuals at risk for Alzheimer’s disease type dementia. The purpose of this study is to improve our understanding of brain aging and dementia in Down syndrome.

Participation in this study will require yearly visits which consist of medical evaluation, neurologic evaluation, and assessments measuring your memory, thinking, and functional skills. The research visits will be conducted at the UC Irvine Institute for Clinic and Translational Science which has offices at both the UC Irvine campus in Irvine and the UC Irvine Medical Center in Orange. Participants can choose the research site of their preference. Each visit is expected to last approximately four to five hours. The evaluations in the study will be provided to participants at no cost.

There are no direct benefits of participation, however, the participant themselves, other individuals with Down syndrome, or the population as a whole may benefit from the conclusions drawn from the results of this study. Participants will not receive any compensation for their participation.

Biomarker of Alzheimer’s Disease in Down Syndrome Study

Researchers at the University of California, Irvine under the direction of Dr. Ira T. Lott, are seeking healthy adults with Down syndrome to participate in a research study about brain aging and Alzheimer’s disease. People with Down syndrome are at significantly increased risk to develop Alzheimer’s disease by age 40 years.

The study, entitled “Biomarker of Alzheimer’s Disease in Down Syndrome” will investigate biological factors that may be related to the development of Alzheimer’s disease in adults with Down syndrome. These biomarkers are likely to be important for the discovery of future therapies.

Approximately 100 adults with Down syndrome are sought to participate in the study. To be eligible, participants must have Down syndrome (with or without Alzheimer’s disease), and be age 40 or older. Study participants will be involved for a total of approximately 3 years of evaluations. During this time, participants along with their caregivers or family members will be asked to attend a total of 6-8 visits lasting 2-8 hours each over the study period.

The study includes:

  • Recurring cognitive and neuropsychological tests and questionnaires
  • Recurring medical evaluations including research blood tests
  • Three MRI scans of the brain (optional)
  • Two lumbar punctures for collection of cerebrospinal fluid (optional)

Participants in this study may not revive any direct benefit to participation. Medical evaluations will be available to the participant’s physician. This study parallels research in Alzheimer’s disease within the general populations with a specific focus on Down syndrome.

The evaluations in this study are provided to participants at no cost.

Participants will be compensated up to $310.

If you know someone who may be interested in participating, or would like more information about these studies, please contact the study coordinator:

Eric Doran at 714.456.8443 or edoran@uci.edu
UC Irvine Medical Center, Department of Pediatric

THE 90+ STUDY

What is The 90+ Study?

The 90+ Study is a research study to examine successful aging and dementia in those aged 90 years and beyond.

Who can join?

People 90 years or older who live in Southern California and are willing to undergo study procedures.

What is involved?
  • One-time MRI and amyloid PET imaging of the brain
  • Examinations and clinical assessment every 6 months
    • One hour of testing your memory and thinking skills
    • One hour neurological and physical exam
    • Review of medical and family histories and medications
    • Examinations and clinical assessment every 6 months
  • Brain donation upon death
Where do I have to go?

Clinical exams take place in the research office in Laguna Woods, CA or in your own home. Brain imaging is done in centers in Irvine and Newport Beach, CA. Transportation is provided if necessary.

What will The 90+ Study cost?

There is no cost to you. The 90+ Study is funded by the National Institutes of Health.

What is Involved?

With your participation in The 90+ Study, we hope to learn ways to improve quality of life for people as they grow older. Your participation may help others reach 90 years of age and beyond in better health.

Contact us today to get started!

Study Website: www.90study.org
Phone: 949.768.3635
Email: study90@uci.edu
Address: 24361 El Toro Road Suite 150, Laguna Woods, CA 92867